Berberine

Pronunciation: BER-ber-een.

Generic name
berberine
Drug class
Plant alkaloid dietary/food supplement (not an approved drug)
Form
Capsule, tablet
Route
Oral
Legal status
Dietary/food supplement or listed complementary product (non-prescription) in every market reviewed; not an approved prescription or OTC drug anywhere reviewed

Availability and supply rules vary by country

Trade names by country: United States

Australia: · Full directory

What berberine is and how it works

Berberine is a plant alkaloid sold as a dietary/food supplement, marketed for blood sugar and cholesterol support. It is not an FDA-approved drug or an approved medicine in any of the markets reviewed here, and its regulatory oversight and pre-market evidence requirements are generally lighter than for a prescription or OTC medicine. (1)

Evidence for berberine's marketed claims is limited and mixed -- some small human studies suggest possible effects on blood sugar or cholesterol, but many have important limitations (small size, short duration, bias risk, and participants who already had conditions like diabetes). Talk with a clinician before starting berberine, especially if you take other medicines, are pregnant or breastfeeding, or are considering it for a child.

Mechanism of action: how berberine works

Berberine is an isoquinoline alkaloid studied for effects including AMPK activation and modulation of glucose and lipid metabolism pathways; it also inhibits CYP3A4 and CYP2D6 liver enzymes, and displaces bilirubin from serum albumin, the documented mechanism behind its newborn/infant jaundice risk. (1) (6)

What berberine is used for

Marketed for blood sugar support

Berberine is marketed as a supplement to support healthy blood sugar levels. Some small human studies suggest a possible effect, but the overall evidence base is limited, with variable study quality and dosing -- it is not a substitute for prescribed diabetes treatment. (1) (3)

Marketed for cholesterol support

Berberine is also marketed to support healthy cholesterol levels. As with blood sugar claims, human evidence is limited and mixed, and berberine should not replace medicines or lifestyle measures recommended by a clinician. (3)

Marketed for weight management

Some products are marketed for weight loss. A 2022 review of 18 studies found possible reductions in weight and BMI, particularly at doses above 1 gram daily for more than 8 weeks, but many of these studies carried a high risk of bias, used varying formulations and doses, and mostly involved people who already had conditions such as diabetes or fatty liver disease. Additional high-quality research is needed before firm conclusions can be drawn. (1)

Before taking berberine

Do not take / not appropriate for

  • Do not give berberine to infants or newborns -- it can displace bilirubin from albumin in the blood and has been linked to kernicterus, a rare but serious form of brain damage from severe newborn jaundice. (all countries) (1) (2)
  • Avoid berberine during pregnancy or while breastfeeding unless specifically directed by a clinician, because of the bilirubin-related newborn risk described above, traditional concerns about a possible uterine-stimulant effect, and the fact that berberine is known to cross the placenta. (all countries) (1)

Tell your clinician about

  • All prescription and over-the-counter medicines you take, since berberine can affect liver enzymes (CYP3A4, CYP2D6) that process many drugs, creating a wide range of possible interactions.
  • If you take cyclosporine (an immunosuppressant) -- this is the interaction with the strongest documented human evidence.
  • If you take medicines for diabetes, since berberine may add to blood-sugar-lowering effects.
  • If you are pregnant, trying to become pregnant, or breastfeeding.
  • If berberine is being considered for a child -- evidence and safety data in children are very limited.
(1)

How to take berberine

  • Follow the dose stated on the product label, since dietary supplements are not subject to the same fixed, clinically-established dosing as approved medicines.
  • Discuss the intended use, dose, and duration with a clinician or pharmacist, particularly if combining berberine with other medicines or supplements.
  • Studies showing possible effects have generally used doses of around 1 gram or more per day for 8 weeks or longer, but this reflects research dosing, not an individually validated recommendation for you.
(1)

Procedures and treatment changes

Tell the treating team before surgery, procedures, or any medicine change. Do not alter treatment without the responsible clinician. (1) (2) (3) (4) (5) (6) (7)

Missed dose

Because berberine is a supplement without a fixed clinical dosing schedule, simply resume your usual label-directed use; there is no established rule requiring a double dose. If you have questions about your specific product or routine, check with a pharmacist or clinician.

Overdose

If a large amount has been taken, especially by a child, or if severe gastrointestinal symptoms or any other concerning symptoms occur, contact a doctor, pharmacist, or poison control service promptly. (1)

Side effects

Side effects and their urgency vary; report severe, persistent, or concerning symptoms.

Nausea.

What to notice: Nausea.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)

Abdominal pain.

What to notice: Abdominal pain.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)

Bloating.

What to notice: Bloating.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)

Constipation or diarrhea.

What to notice: Constipation or diarrhea.

What to do: Discuss persistent or troublesome symptoms with the treating clinician or pharmacist. (1)

Serious warnings

Newborn/infant jaundice risk (kernicterus) — high caution

Symptoms: Yellowing of the skin or eyes (jaundice), unusual sleepiness, or poor feeding in a newborn.

Action: Do not give berberine to infants or newborns. If a newborn shows signs of jaundice, seek medical assessment promptly regardless of any berberine exposure -- this is a genuine, well-documented safety concern based on berberine's bilirubin-displacement effect. (1) (2)

Signs of a significant drug interaction (e.g. with cyclosporine or diabetes medicines) — high caution

Symptoms: Unusual symptoms after starting berberine alongside another medicine, such as signs of low blood sugar (shakiness, sweating, confusion) if combined with diabetes medicines.

Action: Contact your prescriber promptly if you notice new or worsening symptoms after combining berberine with another medicine. (1)

Interactions

  • Cyclosporine (an immunosuppressant) -- documented interaction; berberine may raise cyclosporine blood levels. (1)
  • Medicines metabolised by the CYP3A4 or CYP2D6 liver enzymes -- berberine may affect blood levels of a wide range of drugs processed by these enzymes; discuss any prescription medicines with a clinician before combining. (1)
  • Diabetes medicines -- berberine may add to blood-sugar-lowering effects, increasing the risk of low blood sugar. (1)

Pregnancy, breastfeeding, kidney/liver function, age

Pregnancy

Avoid berberine during pregnancy unless specifically directed by a clinician. Concerns include a traditional caution about possible uterine-stimulant effects, known placental transfer, and the bilirubin-related risk to a newborn described above. (1) (2) (3) (4) (5) (6) (7)

Breastfeeding

Avoid berberine while breastfeeding unless specifically directed by a clinician, given the documented bilirubin-displacement effect and potential newborn risk. (1) (2) (3) (4) (5) (6) (7)

Children

Do not give berberine to infants or newborns because of the kernicterus/bilirubin-displacement risk. Evidence and safety data in older children are very limited; use only on specific clinician advice. (1) (2) (3) (4) (5) (6) (7)

Elderly

No age-specific dosing guidance is established for older adults in the sources reviewed; discuss use with a clinician, particularly given the potential for drug interactions common in this age group. (1) (2) (3) (4) (5) (6) (7)

Hepatic_impairment

Discuss any liver condition with a clinician before use, given berberine's effect on liver-enzyme-metabolised drugs. (1) (2) (3) (4) (5) (6) (7)

Renal_impairment

No specific renal-impairment guidance is established in the sources reviewed; discuss any kidney condition with a clinician before use. (1) (2) (3) (4) (5) (6) (7)

Source_ids

US-NCCIH-BERBERINE-2026,PUBMED-BERBERINE-BILIRUBIN-DISPLACEMENT-1993 (1) (2) (3) (4) (5) (6) (7)

Monitoring

Before starting

  • Review of all current medicines for possible CYP3A4/CYP2D6-mediated interactions
  • Discussion of realistic evidence strength for the intended use with a clinician or pharmacist

During treatment

  • Watching for gastrointestinal side effects (nausea, bloating, diarrhea, constipation).
  • Monitoring blood sugar more closely if also taking diabetes medicines.
  • Reviewing ongoing need and evidence with a clinician periodically, given the limited long-term human data.
(1)

Storage

Store at room temperature, away from moisture and heat, and out of reach of children -- keep in mind the specific and serious risk berberine poses to infants and young children.

Professional information

Clinician-facing context only, sourced from NCCIH (NIH) and the peer-reviewed bilirubin-displacement literature; berberine is a supplement, not an approved drug, so no regulator-established prescribing information exists in the way it does for a licensed medicine.

General (no regulator-established dose in any market reviewed)

Indication: Marketed blood sugar / cholesterol / weight-management support

Dose summary: Human studies reviewed by NCCIH have generally used approximately 1 gram or more per day for 8 weeks or longer, with wide variation in formulation and duration; this reflects research dosing, not an approved or individually validated therapeutic dose.

Renal context: Not established in the sources reviewed for this dossier. (1)

Mechanism of action

Hepatic guidance

Idiosyncratic liver injury has been raised as a concern in the EU EFSA draft safety review of berberine-containing preparations; monitor for signs of liver problems and discuss any pre-existing liver disease with a clinician before use.

Overdose note

Limited data exist on berberine overdose in humans; gastrointestinal symptoms are the most likely effect at excessive doses. Seek medical or poison-control advice for any suspected overdose, especially in a child. (1) (6)

Frequently asked questions

Is berberine an approved medicine?

No. In every market reviewed here (United States, United Kingdom, European Union, Canada, Australia, and New Zealand), berberine is sold as a dietary/food supplement or listed complementary product, not as an FDA- or regulator-approved medicine, and marketed disease-treatment claims are not permitted without separate drug approval. (1) (5) (6) (3) (4) (7)

Is there an EU safety concern about berberine?

Yes. As of 2026, the European Food Safety Authority (EFSA) has published a draft safety opinion concluding that a safe intake level could not currently be established for berberine-containing plant preparations, citing genotoxicity signals, rodent carcinogenicity findings, and reports of liver injury. This is a draft under review, not a finalised EU-wide ban -- but it is a real, current safety signal worth discussing with a clinician or pharmacist before use. (6)

Can berberine be given to babies or taken during pregnancy?

No, berberine should not be given to infants or newborns because of a documented risk of displacing bilirubin and contributing to kernicterus (a rare, serious form of newborn brain damage from severe jaundice). It should also be avoided during pregnancy and breastfeeding unless a clinician specifically directs otherwise. (1) (2)

What is the mechanism of action of berberine?

Berberine is an isoquinoline alkaloid studied for effects including AMPK activation and modulation of glucose and lipid metabolism pathways; it also inhibits CYP3A4 and CYP2D6 liver enzymes, and displaces bilirubin from serum albumin, the documented mechanism behind its newborn/infant jaundice risk. (1) (6)

What is the generic name of Berberine?

The generic name is berberine. (1)

What class of drug is berberine?

Berberine is classed as: Plant alkaloid dietary/food supplement (not an approved drug). (1)

References

  1. Berberine and Weight Loss: What You Need To KnowNational Center for Complementary and Integrative Health (NCCIH), part of the U.S. National Institutes of Health · United States · accessed 2026-07-30 · source 1
  2. Displacement of Bilirubin from Albumin by BerberinePubMed / peer-reviewed neonatology literature (Karger Publishers) · international (cited by US NCCIH and other regulators) · accessed 2026-07-30 · source 2
  3. Berberine (as Berberine hydrochloride) -- Natural Health Products Ingredients Database and Licensed Natural Health Products Database entriesHealth Canada -- Natural Health Products Directorate / Licensed Natural Health Products Database (LNHPD) · Canada · accessed 2026-07-30 · source 3
  4. Berberine products -- ARTG listings (e.g. BERBERINE 500, Berberine Complex, Berberine ImmunoPlex)Therapeutic Goods Administration (TGA), Australia · Australia · accessed 2026-07-30 · source 4
  5. Berberine as a UK food supplement under the Food Supplements (England) Regulations 2003 and MHRA borderline-products guidanceUK Medicines and Healthcare products Regulatory Agency (MHRA) borderline-products framework / Food Standards Agency food-supplement law · United Kingdom · accessed 2026-07-30 · source 5
  6. Draft opinion on the safety of berberine and berberine-containing plant preparations (Berberis, Chelidonium majus, Hydrastis canadensis, Phellodendron amurense) -- public consultationEuropean Food Safety Authority (EFSA) Panel on Nutrition, Novel Foods and Food Allergens (NDA) · European Union · accessed 2026-07-30 · source 6
  7. Regulation of Dietary Supplements (New Zealand)Medsafe (New Zealand regulator) -- Dietary Supplements Regulations 1985 · New Zealand · accessed 2026-07-30 · source 7

Brand names by country

Single-ingredient berberine names are shown separately by country. Product availability, strengths, and supply rules can change; combination products are not included here.

Priority countries

United States

  • AN Amazing Nutrition Amazing FormulasAN Amazing Nutrition Amazing Formulas
  • XYMOGENXYMOGEN
  • HerbadietHerbadiet
  • Integrative TherapeuticsIntegrative Therapeutics
  • Wonder LabsWonder Labs
  • EuroMedicaEuroMedica
  • EnzymedicaEnzymedica
  • Good StateGood State
  • Source NaturalsSource Naturals
  • SolaraySolaray
View brands in additional countries.

This page provides general reference information about berberine, a dietary supplement, and is not a substitute for advice from a doctor or pharmacist. Berberine is not an approved medicine in the markets reviewed, and its evidence base for marketed claims is limited.

Related conditions